Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
SoundThinking
SSTI
$101M
| $2.45M | ﹤0.01% |
72,332
-6,200
| -8% | -$207K |
|
|
ALPN
1952
DELISTED
Alpine Immune Sciences Inc
ALPN
| $2.45M | ﹤0.01% |
332,894
-25,800
| -7% | -$165K |
|
|
WCC
1953
WESCO International
WCC
$18.2B
| $2.44M | ﹤0.01% |
+19,474
| New | +$2.45M |
|
1954
Huazhu Hotels Group
HTHT
$13B
| $2.43M | ﹤0.01% |
57,200
+19,000
| +50% | +$687K |
|
1955
Eastern Company
EML
$147M
| $2.42M | ﹤0.01% |
125,437
-11,200
| -8% | -$233K |
|
1956
Xperi
XPER
$377M
| $2.42M | ﹤0.01% |
+280,573
| New | +$3.21M |
|
1957
Live Oak Bancshares
LOB
$2.02B
| $2.41M | ﹤0.01% |
79,900
-91,800
| -53% | -$2.93M |
|
1958
LeMaitre Vascular
LMAT
$1.8B
| $2.41M | ﹤0.01% |
52,400
-500
| -0.9% | -$23.4K |
|
1959
Interparfums
IPAR
$3.96B
| $2.4M | ﹤0.01% |
24,913
-41,000
| -62% | -$3.56M |
|
|
RPTX
1960
DELISTED
Repare Therapeutics
RPTX
| $2.4M | ﹤0.01% |
163,400
+28,279
| +21% | +$423K |
|
|
JAMF
1961
DELISTED
Jamf
JAMF
| $2.4M | ﹤0.01% |
112,600
+24,600
| +28% | +$541K |
|
1962
Hope Bancorp
HOPE
$1.82B
| $2.4M | ﹤0.01% |
187,064
+135,364
| +262% | +$1.79M |
|
1963
Flexsteel Industries
FLXS
$316M
| $2.4M | ﹤0.01% |
155,493
-15,200
| -9% | -$228K |
|
|
IBDO
1964
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
| $2.39M | ﹤0.01% |
95,600
+81,500
| +578% | +$2.03M |
|
1965
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.25B
| $2.39M | ﹤0.01% |
+104,293
| New | +$2.36M |
|
1966
Civista Bancshares
CIVB
$599M
| $2.39M | ﹤0.01% |
108,465
+7,200
| +7% | +$162K |
|
|
IVAC
1967
DELISTED
Intevac Inc
IVAC
| $2.39M | ﹤0.01% |
368,992
-23,000
| -6% | -$123K |
|
|
CVLY
1968
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $2.38M | ﹤0.01% |
100,205
-14,233
| -12% | -$311K |
|
1969
Oshkosh
OSK
$9.43B
| $2.38M | ﹤0.01% |
+27,000
| New | +$2.32M |
|
1970
RLI Corp
RLI
$5.77B
| $2.38M | ﹤0.01% |
36,200
+31,600
| +687% | +$1.97M |
|
1971
Parke Bancorp
PKBK
$401M
| $2.38M | ﹤0.01% |
114,534
-11,632
| -9% | -$246K |
|
1972
Fiverr
FVRR
$340M
| $2.37M | ﹤0.01% |
81,400
+15,900
| +24% | +$499K |
|
1973
Prudential
PUK
$34.8B
| $2.36M | ﹤0.01% |
86,000
-14,800
| -15% | -$338K |
|
|
CALY
1974
Callaway Golf Company
CALY
$3.43B
| $2.36M | ﹤0.01% |
119,600
-100,900
| -46% | -$1.99M |
|
1975
Virtus Investment Partners
VRTS
$1.08B
| $2.36M | ﹤0.01% |
12,329
-3,800
| -24% | -$680K |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.